Skip to main content
. 2021 Jul 29;12:547333. doi: 10.3389/fimmu.2021.547333

Figure 5.

Figure 5

The evaluation of immune microenvironment in high- and low-risk patients with AD and SCC. The evaluation of immune cell infiltration for AD cohort (A) and SCC cohort (B). The evaluation of tumor immune microenvironment based on TIDE for AD cohort (C) and SCC cohort (D), and the grading system contain TIDE score, T cell Dysfunction Score and Exclusion Score. (E) The prediction of response to ICI treatment for SCC patients in high- and low-risk groups.